Exagen, Inc. (XGN)
6.08
+0.07
(+1.16%)
USD |
NASDAQ |
Dec 31, 16:00
6.10
+0.02
(+0.33%)
After-Hours: 20:00
Exagen Free Cash Flow: -10.99M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| FONAR Corp. | 7.016M |
| XWELL, Inc. | -15.12M |
| ProPhase Labs, Inc. | -11.15M |
| Veracyte, Inc. | 98.21M |
| Insight Molecular Diagnostics, Inc. | -23.91M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.944M |
| Cash from Investing (Quarterly) | -0.275M |
| Cash from Financing (Quarterly) | 2.95M |
| Free Cash Flow Per Share (Quarterly) | 0.1163 |
| Free Cash Flow to Equity (Quarterly) | -0.294M |
| Free Cash Flow to Firm (Quarterly) | 3.988M |
| Free Cash Flow Yield | -8.93% |